Data Foundry

Drug recalls 2016

Sensorcaine- MPF — Class II drug recall D-1037-2016

Terminated recall by Fresenius Kabi USA, LLC, reported 2016-06-22, distributed nationwide. Presence of Particulate Matter: Glass particulate found in sterile injectable product

Recall numberD-1037-2016
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmFresenius Kabi USA, LLC, Lake Zurich, IL, United States
Recall initiated2016-04-25
Classified2016-06-16
Reported by FDA2016-06-22
Terminated2016-10-20
DistributedNationwide (US)
Quantity69,225 units
Reason classesforeign material, sterility, specification failure
NDC63323-0461, 63323-0461-01, 63323-0461-57, 63323-0463, 63323-0463-01, 63323-0463-57, 63323-0468, 63323-0468-01, 63323-0468-02, 63323-0468-17, 63323-0468-37, 63323-0472, 63323-0472-01, 63323-0472-03, 63323-0472-17, 63323-0472-37
Lot numbers6111504
Expiration dates2019-09

Product

Sensorcaine- MPF (Bupivacaine HCI Injection, USP), 0.75% in a 30 mL Single Dose Vial, Rx only, Fresenius Kabi USA LLC, Lake Zurich, IL 60047, NDC 63323-472-37

Reason for recall

Presence of Particulate Matter: Glass particulate found in sterile injectable product

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1037-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.